SWOT Analysis for Amrutanjan Health Care Ltd.

Company with No Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
FII / FPI or Institutions increasing their shareholding
MACD crossed above signal line previous end of day

MACD Crossover Below Signal Line
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score	53938.8% returns for over 6.3 years
Degrowth in Revenue and Profit
Decline in Net Profit with falling Profit Margin (QoQ)
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
Major fall in TTM Net Profit
Fall in Quarterly Revenue and Net Profit (YoY)

Companies with growing costs YoY for long term projects
Expensive Performers (DVM)	550.5% returns for Nifty 500 over 10.2 years
High PE (PE > 40)
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks	187.6% returns for Nifty 500 over 4.5 years
Stocks with Expensive Valuations according to the Trendlyne Valuation Score	177.2% returns for Nifty 500 over 4.5 years
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
MFs increased their shareholding last quarter
Top Gainers
Near 52 Week Low